Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8166
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma ; volume:8 ; number:1 ; day:17 ; month:10 ; year:2015 ; pages:1-9 ; date:12.2015
Molecular cytogenetics ; 8, Heft 1 (17.10.2015), 1-9, 12.2015
- Creator
-
Dahle-Smith, Åsa
Stevenson, David
Massie, Doreen
Murray, Graeme I.
Dutton, Susan J.
Roberts, Corran
Ferry, David
Osborne, Aileen
Clark, Caroline
Petty, Russell D.
Miedzybrodzka, Zosia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13039-015-0181-0
- URN
-
urn:nbn:de:101:1-2019080402561622938035
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dahle-Smith, Åsa
- Stevenson, David
- Massie, Doreen
- Murray, Graeme I.
- Dutton, Susan J.
- Roberts, Corran
- Ferry, David
- Osborne, Aileen
- Clark, Caroline
- Petty, Russell D.
- Miedzybrodzka, Zosia
- SpringerLink (Online service)
Other Objects (12)
Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours
Diagnostic Criteria for Gastro-esophageal Reflux Following Sleeve Gastrectomy
The potential therapeutic effect of melatonin in gastro-esophageal reflux disease
Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer
The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis
Shared genetic architecture between gastro-esophageal reflux disease, asthma, and allergic diseases
Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease
Improving treatment of people with gastro-esophageal reflux disease refractory to proton pump inhibitors
Nivolumab a New Standard of Care in Adjuvant Settings in Esophageal and Gastroesophageal Junctional Cancer Patients
Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours
Diagnostic Criteria for Gastro-esophageal Reflux Following Sleeve Gastrectomy
The potential therapeutic effect of melatonin in gastro-esophageal reflux disease
Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer
The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis
Shared genetic architecture between gastro-esophageal reflux disease, asthma, and allergic diseases
Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease
Improving treatment of people with gastro-esophageal reflux disease refractory to proton pump inhibitors
Nivolumab a New Standard of Care in Adjuvant Settings in Esophageal and Gastroesophageal Junctional Cancer Patients
Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours
Diagnostic Criteria for Gastro-esophageal Reflux Following Sleeve Gastrectomy
The potential therapeutic effect of melatonin in gastro-esophageal reflux disease
Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer
The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis
Shared genetic architecture between gastro-esophageal reflux disease, asthma, and allergic diseases
Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease
Improving treatment of people with gastro-esophageal reflux disease refractory to proton pump inhibitors